Tylenol maker Kenvue is calling on the Food and Drug Administration to back off a proposed safety label change to acetaminophen after the Trump administration linked its use during pregnancy to autism.

In response to a citizen petition filed last month, the company said the “expansive scientific evidence developed over many years” does not support a causal link between acetaminophen use in pregnancy and developmental disorders.

“Acetaminophen is one of the most studied medicines in history, and scientific evidence regarding acetaminophen use in pregnancy and neurodevelopmental outcomes has been continuously evaluated by FDA and industry for more than a decade,” Kenvue said.

Acetaminophen is the only pain reliever considered safe for pregnant women. The company noted that adopting the ch

See Full Page